Frequently Asked Questions

Get answers to common questions about Semaglutide (1 month supply).

Semaglutide mimics the GLP-1 hormone, slowing gastric emptying and reducing hunger signals. This lowers calorie intake and supports weight loss when paired with diet and exercise, under clinical monitoring.

Ideal candidates are adults meeting BMI or weight-related health criteria who seek medically supervised weight loss. A clinician reviews medical history, medications, pregnancy risk, and contraindications before prescribing.

Common side effects include nausea, vomiting, diarrhea or constipation and temporary digestive discomfort. Rarely, more serious issues like pancreatitis or gallbladder problems occur; report severe symptoms to your provider immediately.

Many clients notice reduced appetite within weeks and measurable weight loss within 4–12 weeks. Individual responses vary; regular visits allow dose adjustments and ongoing support to maximize outcomes.

Yes. Initial evaluation and periodic monitoring of blood glucose, kidney function, and overall tolerance are recommended. Follow-up appointments ensure safe dosing and timely management of any side effects.

Semaglutide is often combined with lifestyle interventions and sometimes other medically supervised treatments. However, combinations require provider review for interactions and safety to create an individualized, effective plan.